small cap « AGORACOM Small-cap Investor Relations Blog

Posts Tagged ‘small cap’

POET Technologies $PTK.ca $POETF to Present at the LD Micro Main Event Virtual Conference on December 15

Posted by AGORACOM-JC at 8:11 AM on Thursday, December 10th, 2020

Suresh Venkatesan, Chairman and Chief Executive Officer, will present at the LD Micro Main Event Conference, which will be held as a virtual event. Management is scheduled to present to a live virtual panel on Tuesday, December 15 ^th at 2:40 p.m. EST.

TORONTO, Dec. 10, 2020 — POET Technologies Inc. (“POET” or the “Company”) (TSX Venture: PTK; OTCQX: POETF), the designer and developer of the POET Optical Interposer™ and Photonic Integrated Circuits (PICs) for the data center and tele-communication markets, announced today that Suresh Venkatesan, Chairman and Chief Executive Officer, will present at the LD Micro Main Event Conference, which will be held as a virtual event. Management is scheduled to present to a live virtual panel on Tuesday, December 15 ^th at 2:40 p.m. EST.

Following the conference a webcast replay of management’s presentation will be available on the “ Presentations & Events ” page in the Investor Relations section of the Company’s website.

About POET Technologies Inc.

POET Technologies is a design and development company offering integration solutions based on the POET Optical Interposer™ a novel platform that allows the seamless integration of electronic and photonic devices into a single multi-chip module using advanced wafer-level semiconductor manufacturing techniques and packaging methods. POET’s Optical Interposer eliminates costly components and labor-intensive assembly, alignment, burn-in and testing methods employed in conventional photonics. The cost-efficient integration scheme and scalability of the POET Optical Interposer brings value to any device or system that integrates electronics and photonics, including some of the highest growth areas of computing, such as Artificial Intelligence (AI), the Internet of Things (IoT), autonomous vehicles and high-speed networking for cloud service providers and data centers. POET is headquartered in Toronto, with operations in Allentown, PA and Singapore. More information may be obtained at www.poet-technologies.com .

Shareholder Contact:
Shelton Group
Brett L. Perry
[email protected]

Company Contact:
Thomas R. Mika, EVP & CFO
[email protected]

This news release contains “forward-looking information” (within the meaning of applicable Canadian securities laws) and “forward-looking statements” (within the meaning of the U.S. Private Securities Litigation Reform Act of 1995). Such statements or information are identified with words such as “anticipate”, “believe”, “expect”, “plan”, “intend”, “potential”, “estimate”, “propose”, “project”, “outlook”, “foresee” or similar words suggesting future outcomes or statements regarding any potential outcome. Such statements include the Company’s expectations with respect to the success of the Company’s product development efforts, the expected results of its operations, meeting revenue targets, and the expectation of continued success in the financing efforts, the capability, functionality, performance and cost of the Company’s technology as well as the market acceptance, inclusion and timing of the Company’s technology in current and future products.

Such forward-looking information or statements are based on a number of risks, uncertainties and assumptions which may cause actual results or other expectations to differ materially from those anticipated and which may prove to be incorrect. Assumptions have been made regarding, among other things, management’s expectations regarding the success and timing for completion of its development efforts, financing activities, receiving full payment for its sale of its DenseLight subsidiary, future growth, plans for and completion of projects by the Company’s third-party consultants, contractors and partners, availability of capital, and the necessity to incur capital and other expenditures. Actual results could differ materially due to a number of factors, including, without limitation, operational risks in the completion of the Company’s anticipated projects, delays or changes in plans with respect to the development of the Company’s anticipated projects by the Company’s third-party relationships, risks affecting the Company’s ability to execute projects, the ability of the Company to generate sales for its products, the ability to attract key personnel, and the ability to raise additional capital. Although the Company believes that the expectations reflected in the forward-looking information or statements are reasonable, prospective investors in the Company’s securities should not place undue reliance on forward-looking statements because the Company can provide no assurance that such expectations will prove to be correct. Forward-looking information and statements contained in this news release are as of the date of this news release and the Company assumes no obligation to update or revise this forward-looking information and statements except as required by law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

120 Eglinton Avenue, East, Suite 1107, Toronto, ON, M4P 1E2- Tel: 416-368-9411 – Fax: 416-322-5075

Tags: AI, Cloud Computing, lightbar, photonics, small cap, small cap stocks, stocks, tech, tech stocks
Posted in POET Technologies | Comments Off on POET Technologies $PTK.ca $POETF to Present at the LD Micro Main Event Virtual Conference on December 15

ImagineAR $IP.ca $IPNFF Announces Agreement with Indian Superstar Singer Ananya Birla $DBO.ca $YDX.ca $SEV.ca $NTAR.ca

Posted by AGORACOM-JC at 7:06 AM on Thursday, December 10th, 2020

http://www.smallcapepicenter.com/imagine%20ar%20squre.jpg

Ananya Birla Leading ImagineAR Consumer & Business Launch in India

Announced a partnership agreement with Indian Superstar Singer Ananya Birla to spearhead the ImagineAR consumer launch in India.
With over 350 million streams of her songs on streaming platforms, Ananya’s fan base is growing exponentially.
She also is the only multi-platinum selling English singer in India , pioneering many firsts in the global music scene.

VANCOUVER , BC and ERIE, Pa. , Dec. 10, 2020 – ImagineAR (CSE: IP) (OTCQB: IPNFF) an Augmented Reality company that enables sports teams, entertainers, brands and businesses to instantly create their own global mobile phone AR campaigns, is excited to announce a partnership agreement with Indian Superstar Singer Ananya Birla to spearhead the ImagineAR consumer launch in India. With over 350 million streams of her songs on streaming platforms, Ananya’s fan base is growing exponentially. She also is the only multi-platinum selling English singer in India , pioneering many firsts in the global music scene.

ImagineAR Announces Agreement with Indian Superstar Singer Ananya Birla (CNW Group/ImagineAR)

Ananya Birla said “Technology plays a pivotal role in having one’s music reach a wider audience. I am excited to be partnering with a technology leader like ImagineAR to break new ground with technology in music. I want to thank Greg Thompson , my strategic manager and mentor, for playing such an integral role in this project.”

Greg Thompson , President of Maverick and Manager for Ananya Birla , “Ananya’s partnership with ImagineAR provides a great opportunity to continue to expand her global brand while bringing her relationship with her fans into an even greater level of connection”.

“Ananya is truly a role model for today’s women as a successful singer, entrepreneur and mental health advocate”, stated Alen Paul Silverrstieen CEO of ImagineAR, “We are proud and honored to be represented by Ananya as ImagineAR expands into the Indian consumer marketplace. We thank Mike Tunnicliffe , our ImagineAR Board of Director, for introducing our company to Greg Thompson of Maverick and Ananya.”

About Ananya Birla

“Her empowering spirit translates directly to her music” – Billboard

“An Indian born, London -bred badass who serves an inspiration to marginalized youth and women of all continents ” – Euphoria

“An integral part of her nation’s music history” – Schon

“One of the most striking artists on the interna tion a l pop scene ” – FabUK

“Ananya Birla’s ‘Fingerprint’ EP is a whole snack ” – Earmilk

“A woman to watch”- My Domaine

“She is ready to become a breakout artist worldwide” – Ones To Watch

“Ananya Birla is a name and sound to be remembered” – Play It By Ear

“A whirlwind of talent and ambition” – Rookie Mag

Ananya is a 26-year-old singer-songwriter from Mumbai , based between Mumbai and Los Angeles , where she is signed to Maverick Management.

The first homegrown artist to go Platinum with an English language track in India and that too multiple times, Ananya has hit over 350 million global streams.

Blazing her own path, and recently making history again as the first Indian artist to be played on Top 40 U.S. radio, “Everybody’s Lost” follows the release of Ananya’s first-ever U.S. single “Let There Be Love”. The single received immediate radio support from Radio Disney and SiriusXM Hits 1 (who also named her as a ‘1 To Watch’). Last year, Ananya released the infectious ‘Day Goes By’ with Jamaican-American hitmaker Sean Kingston , one of the first major collabs between US and Indian music artists. This followed multi-platinum selling hits, ‘Hold On’, ‘Meant To Be’, ‘Circles’, ‘Livin’ the Life’ (remixed by Afrojack), ‘Better’ and the release of her first EP ‘Fingerprint’ with UMG and Island Records, which included hit single ‘Blackout’ featuring Nigerian hip-hop stars Vector and WurlD.

The self-taught santoor and guitar player has been propelled from low-key gigs around London to performing at some of Asia’s biggest music events including Global Citizen, Oktoberfest and Sunburn, and opening for artists like Wiz Khalifa and Coldplay. Ananya has scaled the charts at home and appeared on major playlists and radio stations in the US, UK, Europe, Australia , the Middle East and SE Asia.

Listed as one of GQ’s Most Influential Young Indians and a Forbes Woman to Watch, Ananya is a strong believer in equality.

Ananya launched the Ananya Birla Foundation that aims to address mental health, education, humanitarian relief, climate change, equality and financial inclusion, related causes. The Foundation was kicked off with a COVID-19 relief project that involved providing menstruation kits, PPE kits and protective equipment to women and hospitals across Maharashtra. The Foundation also worked in providing essentials to migrant workers during the pandemic, and has just commenced a pioneering research project for mental health in rural India.

She also promotes female empowerment through her financial technology business Svatantra which serves women entrepreneurs in rural and semi-urban India grow their businesses and become financially independent. Svatantra means ‘freedom’ in Hindi and currently serves over a million women.

https://www.ananyabirla.com/

About ImagineAR

ImagineAR Inc. (CSE: IP) (OTC: IPNFF) is an augmented reality (AR) platform, ImagineARStudio.com, that enables businesses of any size to create and implement their own AR campaigns with no programming or technology experience. Every organization, from professional sports franchises to small retailers, can develop interactive AR campaigns that blend the real and digital worlds. Customers simply point their mobile device at logos, signs, buildings, products, landmarks and more to instantly engage videos, information, advertisements, coupons, 3D holograms and any interactive content all hosted in the cloud and managed using a menu-driven portal. Integrated real-time analytics means that all customer interaction is tracked and measured in real-time. The AR Enterprise platform supports both IOS and Android mobile devices and upcoming wearable technologies.

For more information or to explore working with ImagineAR, please email [email protected] , or visit www.imagineAR.com .

All trademarks of the property of respective owners.

ON BEHALF OF THE BOARD

Alen Paul Silverrstieen
President & CEO
(818) 850-2490
https://twitter.com/IPtechAR
https://www.facebook.com/imaginationparktechnologies
https://www.instagram.com/iptechar
https://www.linkedin.com/company/imagination-park-technologies-inc

We encourage you to do your own due diligence and ask your broker if Imagine AR Inc. (cse: IP) is suitable for your particular investment portfolio*.

The Canadian Securities Exchange has neither approved nor disapproved the contents of this press release. This press release may include ‘forward-looking information’ within the meaning of Canadian securities legislation, concerning the business of the Company. The forward- looking information is based on certain key expectations and assumptions made by ImagineAR’s management. Although Imagine AR believes that the expectations and assumptions on which such forward- looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because Imagine AR can give no assurance that it will prove to be correct. These forward-looking statements are made as of the date of this press release, and Imagine AR disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

Tags: Apple, AR, augmented reality, Camerai, CSE, D-BOX Technologies Inc., investment, small cap, small cap stocks, stocks, Tipit, tsx
Posted in Imagine AR | Comments Off on ImagineAR $IP.ca $IPNFF Announces Agreement with Indian Superstar Singer Ananya Birla $DBO.ca $YDX.ca $SEV.ca $NTAR.ca

POET $PTK.ca $POETF Launches Campaign with AGORACOM for Online Marketing and Social Media Engagement

Posted by AGORACOM-JC at 8:16 AM on Wednesday, December 9th, 2020

Announced that it has launched a marketing campaign through AGORACOM for the purposes of raising the visibility and awareness of the Company on key online platforms while also facilitating education and increased understanding of POET’s technology, development progress and market opportunities.
The POET HUB, containing multiple landing pages, videos, photos and other helpful information, will be updated regularly over the course of the engagement and go-live on December 10, 2020 at: https://agoracom.com/ir/POETTechnologies

TORONTO, Dec. 09, 2020 — POET Technologies Inc. (“POET” or the “Company”) (TSX Venture: PTK; OTCQX: POETF), the designer and developer of the POET Optical Interposer™ and Photonic Integrated Circuits (PICs) for the data center and tele-communication markets, is pleased to announce that it has launched a marketing campaign through AGORACOM for the purposes of raising the visibility and awareness of the Company on key online platforms while also facilitating education and increased understanding of POET’s technology, development progress and market opportunities.

Significant Exposure Through AGORACOM Digital Network
In 2019, AGORACOM has served over 350 public companies and surpassed 600 million page views, exceeding industry engagement metrics by over 400%.

The POET HUB, containing multiple landing pages, videos, photos and other helpful information, will be updated regularly over the course of the engagement and go-live on December 10, 2020 at: https://agoracom.com/ir/POETTechnologies

The POET HUB will receive significant exposure through continuous brand impression, content marketing, search engine marketing and social media engagement throughout the entire AGORACOM network. AGORACOM is the only small-cap marketing firm to hold a Twitter Verified badge, averaging 4.2 million Twitter impressions per month in 2019.

“Beyond The Press Release” Interviews on AGORACOM Discussion Forum
POET has also launched a Discussion Forum on AGORACOM that will serve as a media and communications platform to provide expanded information about the Company and its technology to both current and prospective shareholders in a fully moderated environment. The new Discussion Forum will exclusively feature a “Beyond the Press Release” interview series with POET’s executive management team, which will include in-depth reviews and highlights from the Company’s most recent press releases. The first of the “Beyond The Press Release” Interviews can be found at: https://agoracom.com/ir/POETTechnologies/forums/discussion/topics/750580-video-poet-technologies-launch-of-lightbar-for-data-centers-is-an-inflection-point-for-the-company/messages/2291701#message

The POET discussion forum can be found at: https://agoracom.com/ir/POETTechnologies/forums/discussion

Verified officers at launch will be: Vivek Rajgarhia, President & General Manager and Thomas Mika, Executive Vice President and Chief Financial Officer.

The AGORACOM marketing campaign is scheduled to run for a period of 12-months at a total annual cost of C$75,000 plus HST, which will be paid entirely in shares of POET’s common stock at various intervals after services have been rendered. The shares to be issued will not be issued at a discount. The Company will issue 30,268 shares at today’s closing price of C$0.56 associated with the initial payment for services rendered to-date. The issuance of all shares related to the marketing campaign agreement are subject to the TSX Venture Exchange policies and regulatory approvals.

About AGORACOM
AGORACOM is a pioneer of online marketing, broadcasting, conferences and investor relations services to North American small and mid-cap public companies, with more than 300 companies served. AGORACOM is the home of more than 7.7 million investors that visited 55.2 million times and read over 600 million pages of information over the last 10 years. The average visit of 8min 43sec is more than double that of global financial sites, which can be attributed to the implementation and enforcement of the strongest moderation rules in the industry.

About POET Technologies Inc.
POET Technologies is a design and development company offering integration solutions based on the POET Optical Interposer™ a novel platform that allows the seamless integration of electronic and photonic devices into a single multi-chip module using advanced wafer-level semiconductor manufacturing techniques and packaging methods. POET’s Optical Interposer eliminates costly components and labor-intensive assembly, alignment, burn-in and testing methods employed in conventional photonics. The cost-efficient integration scheme and scalability of the POET Optical Interposer brings value to any device or system that integrates electronics and photonics, including some of the highest growth areas of computing, such as Artificial Intelligence (AI), the Internet of Things (IoT), autonomous vehicles and high-speed networking for cloud service providers and data centers. POET is headquartered in Toronto, with operations in Allentown, PA and Singapore. More information may be obtained at www.poet-technologies.com .

Shareholder Contact for POET: Shelton Group Brett L. Perry [email protected]	Company Contact for POET: Thomas R. Mika, EVP & CFO [email protected]

This news release contains “forward-looking information” (within the meaning of applicable Canadian securities laws) and “forward-looking statements” (within the meaning of the U.S. Private Securities Litigation Reform Act of 1995). Such statements or information are identified with words such as “anticipate”, “believe”, “expect”, “plan”, “intend”, “potential”, “estimate”, “propose”, “project”, “outlook”, “foresee” or similar words suggesting future outcomes or statements regarding any potential outcome. Such statements include the Company’s expectations with respect to the success of the Company’s product development efforts, the performance of its products, the expected results of its operations, meeting revenue targets, and the expectation of continued success in the financing efforts, the capability, functionality, performance and cost of the Company’s technology as well as the market acceptance, inclusion and timing of the Company’s technology in current and future products.

Such forward-looking information or statements are based on a number of risks, uncertainties and assumptions which may cause actual results or other expectations to differ materially from those anticipated and which may prove to be incorrect. Assumptions have been made regarding, among other things, management’s expectations regarding the success and timing for completion of its development efforts, financing activities, future growth, recruitment of personnel, opening of offices, the form and potential of its planned joint venture, plans for and completion of projects by the Company’s third-party consultants, contractors and partners, availability of capital, and the necessity to incur capital and other expenditures. Actual results could differ materially due to a number of factors, including, without limitation, the failure of its products to meet performance requirements, operational risks in the completion of the Company’s anticipated projects, a delay or abandonment of its planned joint venture, delays in recruitment for its newly opened operations or changes in plans with respect to the development of the Company’s anticipated projects by third-parties, risks affecting the Company’s ability to execute projects, the ability of the Company to generate sales for its products, the ability to attract key personnel, and the ability to raise additional capital. Although the Company believes that the expectations reflected in the forward-looking information or statements are reasonable, prospective investors in the Company’s securities should not place undue reliance on forward-looking statements because the Company can provide no assurance that such expectations will prove to be correct. Forward-looking information and statements contained in this news release are as of the date of this news release and the Company assumes no obligation to update or revise this forward-looking information and statements except as required by law.

120 Eglinton Avenue, East, Suite 1107, Toronto, ON, M4P 1E2- Tel: 416-368-9411 – Fax: 416-322-5075

Tags: AI, Cloud Computing, lightbar, photonics, small cap, small cap stocks, stocks, tech, tech stocks, tsx
Posted in POET Technologies | Comments Off on POET $PTK.ca $POETF Launches Campaign with AGORACOM for Online Marketing and Social Media Engagement

Valeo Pharma $VPH.ca $VPHIF Announces Health Canada Approval for #Redesca™ and Redesca Hp™

Posted by AGORACOM-JC at 7:37 AM on Wednesday, December 9th, 2020

Commercial launch to impact first half 2021 revenue
$30 million forecasted annual peak sales
8 years of proven in-market safety Internationally
Low molecular weight heparin increasingly used to prevent COVID-19 driven complications

MONTREAL , Dec. 9, 2020 – Valeo Pharma Inc . (CSE:VPH) (OTCQB: VPHIF) (FSE: VP2) (” Valeo ” or the ” Company “), a Canadian pharmaceutical company, announced today that Health Canada has issued a Notice of Compliance for Redesca and Redesca HP low molecular weight heparin (“LMWH”) biosimilars.

“The regulatory approval of Redesca is a significant corporate milestone for Valeo and also great news for the Canadian healthcare system. Mandatory use of biosimilars is increasingly being adopted across the country and is expected to help provide significant savings to provincial healthcare plans”, said Steve Saviuk , President and CEO. “With more than 8 years of proven in-market safety internationally and a robust supply chain ensuring product availability, we expect Redesca to play a major role in the achievement of our growth objectives”.

“The Canadian LMWH market is in excess of $200 Million annually and our complete product line and differentiating clinical package will be a beneficial factor helping to rapidly secure market share in provinces across Canada ,” added Mr. Saviuk.

In addition to being used primarily for treating and preventing deep vein thrombosis and pulmonary embolism, LMWH are also now increasingly used as a first line of defense tool in the fight against Covid-19. The World Health Organization’s (“WHO”) issued guidance regarding the prophylaxis use of LMWH to help prevent complications in the clinical management of severe acute respiratory infections when novel coronavirus (COVID-19) infection is suspected.

Digital Investor Awareness Program

The Company also announces that it has launched a 12-month digital investor awareness program through AGORACOM, a multifaceted digital platform operated by AGORA Internet Services Corp. (“AGORA”), in order to enhance information availability for current and future stakeholders. The Company has agreed to remunerate AGORA $75,000 plus taxes for the above mentioned services. A first service payment of $15,000 was made on December 7, 2020 with the remaining balance split equally and due on each of February 27, 2021 , May 27, 2021 , August 27, 2021 , and December 31, 2021

Payment will be made through the issuance of the Company’s common shares with the number of common shares to be issued determined by using the closing price on each date above. Common shares issued to AGORA under this agreement will be subject to a 4-month hold period.

About Redesca

Redesca is a low molecular weight heparin biosimilar. LMWHs are injectable anticoagulant drugs used primarily to treat and prevent deep vein thrombosis and pulmonary embolism. Redesca has more than 8 years of proven in-market safety internationally and more than 150 million patient days treated in Europe alone.

About Valeo Pharma

Valeo Pharma is a pharmaceutical company dedicated to the commercialization of innovative prescription products in Canada with a focus on Neurodegenerative Diseases, Oncology and Hospital Specialty Products. Headquartered in Kirkland, Quebec , Valeo Pharma has the full capability and complete infrastructure to register and properly manage its growing product portfolio through all stages of commercialization. For more information, please visit www.valeopharma.com and follow us on LinkedIn and Twitter .

Forward Looking Statements

This press release contains forward-looking statements about Valeo’s objectives, strategies and businesses that involve risks and uncertainties. These statements are “forward-looking” because they are based on our current expectations about the markets we operate in and on various estimates and assumptions. Actual events or results may differ materially from those anticipated in these forward-looking statements if known or unknown risks affect our business, or if our estimates or assumptions turn out to be inaccurate.

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Tags: investment, pharma, pharma stocks, Redesca, small cap, small cap pharma, stocks, tsx, tsx-v
Posted in Valeo Pharma Inc | Comments Off on Valeo Pharma $VPH.ca $VPHIF Announces Health Canada Approval for #Redesca™ and Redesca Hp™

Kontrol $KNR $KNR.ca $KNR.c $KNRLF to host BioCloud Event for Investors, Analysts and Media $SNE $MSFT $HON $GOOGL $QCOM $SONA.ca

Posted by AGORACOM-JC at 7:33 AM on Wednesday, December 9th, 2020

–Safe Space Technology™–

TORONTO , Dec. 9, 2020 – Kontrol Energy Corp. ( CSE: KNR ) ( OTCQB: KNRLF ) ( FSE: 1K8 ) (” Kontrol ” or ” Company “) is pleased to announce that it will be hosting a webinar presentation for investors, analysts and media for its Covid-19 detection technology (“BioCloud analyzer” or “BioCloud”). The purpose of the presentation is to provide an operating demonstration and take questions from the audience.

“Following the filing of our patent applications we are excited to demonstrate how the BioCloud technology operates and share that with the public,” says Paul Ghezzi , CEO Kontrol. “We will be providing a demonstration of BioCloud and access to the inner workings of the technology.”

As previously announced on November 30, 2020 , Kontrol has filed the following four patent applications for its BioCloud technology and the Company is pleased to provide the patent references:

UNITED STATES : Application No. 17/105,793
SYSTEM AND METHOD FOR DETECTING AIRBORNE PATHOGENS

UNITED STATES : Application No. 17/105,813
SYSTEM AND METHOD FOR OPTICAL DETECTION OF PATHOGENS

UNITED STATES : Application No. 17/105,804
COLLECTION CHAMBER FOR AN AIR SAMPLING SYSTEM

CANADA
SYSTEM AND METHOD FOR DETECTING AIRBORNE PATHOGENS

Title:	Kontrol to Host BioCloud Technology Presentation for Investors, Analysts and Media

Event Date:	Thursday, December 17, 2020 – 4:30 PM Eastern Time

Presentation Type:	Audio with Presenter Controlled Slides and Teleconference

Event Link:	Webcast URL: https://www.webcaster4.com/Webcast/Page/2402/39134

Participant Numbers:	Toll Free: 877-407-0782 International: 201-689-8567

About Kontrol BioCloud TM

BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality over time. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, offices, retirement homes, hospitals, mass transportation and others.

Additional information about Kontrol BioCloud can be found on its website at www.kontrolbiocloud.com

BioCloud is an air quality technology and not a medical device. The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus). Safe Space Technology is a Kontrol Trademark.

About Kontrol Energy

Kontrol Energy Corp., a Canadian public company, is a leader in smart buildings and cities through IoT, Cloud and SaaS technology. Kontrol Energy provides a combination of software, hardware, and service solutions to its customers to improve energy management, air quality and continuous emission monitoring.

Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at www.sedar.com

Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that sufficient capital will be available to the Company and that technology will be as effective as anticipated.

However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected, that customers and potential customers will not be as accepting of the Company’s product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. In particular, successful development and commercialization of the Kontrol BioCloud Analyzer are subject to the risk that the Kontrol BioCloud Analyzer may not prove to be successful in detecting the virus that causes COVID-19 effectively or at all, uncertainty of timing or availability of any regulatory approvals and Kontrol’s lack of track record in developing products for medical applications.

Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date. Kontrol does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.

SOURCE Kontrol Energy Corp.

Tags: BioCloud, COVID-19, CSA, CSA Standards, CSE, energy conservation, google nest, small cap
Posted in Kontrol Energy Corp. | Comments Off on Kontrol $KNR $KNR.ca $KNR.c $KNRLF to host BioCloud Event for Investors, Analysts and Media $SNE $MSFT $HON $GOOGL $QCOM $SONA.ca

VIDEO – POET Technologies $PTK.ca Launch Of LightBar For Data Centers “Is An Inflection Point For The Company”

Posted by AGORACOM-JC at 6:10 PM on Tuesday, December 8th, 2020

Understanding the world of Photonics isn’t the easiest thing small cap investors have had to understand. In fact, it may be the very hardest thing they’ve ever had to understand. However, given the fact we are the very reason current photonics devices aren’t living up to snuff trying to keep up with our surfing, streaming, binging and zooming – you start to see why understanding photonics and POET Technologies could open up investors to a whole new world.

We went beyond the press release with POET management to discuss the launch of their LightBar solution for data centers. They did a great job explaining it in terms that are both compelling yet understandable.

Before watching this video, here is some important background information.

Photonics are critical to the next phase of semiconductor development. Semiconductors are an essential component of every electronic device on the planet.

Photonic devices create, detect and manipulate light. Laser generated light is fundamental to sensing, computing, data and telecommunications, which require the fastest transfer of data possible

For example – the biggest trends in computing today:

Cloud Computing
Artificial Intelligence
5G and Edge

HERE IS THE PROBLEM

Making photonics devices that are reliable is expensive in terms of both capital and labor.

Cost declines have not kept up with Moore’s Law, with most photonics devices built one at a time – and multiple different components must be able to interconnect seamlessly without constant testing.

The Result? Integration of components at wafer-scale has not been fully implemented even by the largest companies working for the past 20 years ….. UNTIL NOW

POET has developed a unique, disruptive and differentiating new entry into photonics markets.

The POET Optical Interposer™ Platform – patented photonics integration platform that enables lower cost and higher performance across a wide range of applications

Today’s press release announcing a line of high-performance remote laser light source products for applications in Cloud-Based Data Centers might very well take POET to a whole new level,

Watch this great first interview of many with

Suresh Venkatesan, Chairman and CEO

Vivek Rajgarhia, President & General Manager

Thomas Mika, Executive Vice President and Chief Financial Officer

Tags: AI, Cloud Computing, lightbar, photonics, small cap, small cap stocks, stocks, tech, tech stocks, tsx, tsx-v
Posted in AGORACOM Via Satellite, Featured, POET Technologies | Comments Off on VIDEO – POET Technologies $PTK.ca Launch Of LightBar For Data Centers “Is An Inflection Point For The Company”

California Cannabis Businesses Praise The Action Taken In Washington On Decriminalization SPONSOR: Harborside $HBOR.ca $VFF.to $HARV.ca $ACB.to

Posted by AGORACOM at 9:37 AM on Tuesday, December 8th, 2020

SPONSOR: Harborside is a California-focused, vertically integrated, fully licensed cannabis company with its business consisting of three primary segments, Retail Dispensaries, Cultivation and Processing and Wholesale Sales (including branded product sales). Harborside operates the only drive through dispensary in California

SAN DIEGO — On Friday the United States House of Representatives passed a bill decriminalizing marijuana at the federal level. Although it is unlikely to pass the Senate, it has industry leaders here in California excited that the conversation towards decriminalization is rolling in Washington.

After receiving some rare bi-partisan support, the Marijuana Opportunity Reinvestment and Expungement or MORE Act passed the House of Representatives by a large margin. Highlights of the bill include:

Decriminalizing marijuana federally
Establishing a 5% federal tax on all cannabis products
Prohibiting the denial of federal benefits to people convicted of cannabis-related crimes
The bill would start the process of expunging the records of those convicted of Cannabis-related offensives

Will Senn is the founder of Urbn Leaf, a marijuana dispensary in San Diego. He says that the bill has been a long time coming and that it was a historic win for the industry. He went on to say that attitudes towards marijuana are shifting around the country. “I think the writing is on the wall, right? Everybody is voting for cannabis legislation nationwide. You had five more states pass some legislation in the last election year. There’s a number of upcoming bills in the near future here.”

Marijuana has been decriminalized in California since 1996 but attitudes about the plant differ drastically around the country. According to the FBI and the Pew Research Center, in 2018 40% of the 1.65 million drug arrests from around the country were marijuana-related and 92% of them were for possession.

Jason Ortiz from the Minority Cannabis Business Association said, “So, I mean, there are thousands at the very minimum, especially on the federal level. But as you start to extend the impact statewide, it could be upwards of millions of records that would get affected.”

Ortiz added that the potential expungement of cannabis-related crimes off a person’s record could change the lives of thousands of people, “And having that on your record denies you access to housing, to jobs, to other sorts of social services.”

Although the bill passed in the House, it’s unlikely that it will see a vote in the Senate. Still, business owners like Senn see it as an important benchmark of just how far the conversation around decriminalizing marijuana has come since he entered the industry.

SOURCE: https://www.cbs8.com/article/news/local/marijuana-opportunity-reinvestment-and-expungement-act/509-a4567228-ad82-4f48-85b3-556e282aa8ed

Tags: American CBD, california cannabis, Cannabis, Canopy Growth Corp, CSE, Greenhouse, Hemp, Record, Revenue, small cap, tsx
Posted in All Recent Posts, Harborside | Comments Off on California Cannabis Businesses Praise The Action Taken In Washington On Decriminalization SPONSOR: Harborside $HBOR.ca $VFF.to $HARV.ca $ACB.to

Canadian-made SARS-CoV-2 detector set to ship worldwide – Kontrol Energy Corp. $KNR $KNR.ca $KNR.c $KNRLF $SNE $MSFT $HON $GOOGL $QCOM $SONA.ca

Posted by AGORACOM-JC at 7:24 AM on Tuesday, December 8th, 2020

Initial sales, distribution agreements, filed patents and Government funding move BioCloud into the market

Set to ship its COVID-19 technology (“Kontrol BioCloud” or “BioCloud”) BioCloud, to customers and distributors around the world.
BioCloud is a real-time analyzer designed to detect airborne viruses, including SARS-COV-2, by continuously sampling air quality and triggering a silent, cloud-based alert to facility managers.

TORONTO , Dec. 8, 2020 – Kontrol Energy Corporation (“Kontrol” or the “Company”), a Canadian public Company (CSE: KNR) (OTCQB: KNRLF), is set to ship its COVID-19 technology (“Kontrol BioCloud” or “BioCloud”) BioCloud, to customers and distributors around the world. BioCloud is a real-time analyzer designed to detect airborne viruses, including SARS-COV-2, by continuously sampling air quality and triggering a silent, cloud-based alert to facility managers.

Initial contracts include sales with Kontrol customers and non-exclusive distribution and an exclusive distribution agreement for North America , Australia and New Zealand with United Safety and Survivability Corp.

Patents Filed
On November 30th, 2020 the Company announced the filing of 4 patents for the BioCloud technology with 3 patents filed in the USA and 1 patent in Canada .

“The focus of our BioCloud technology is to help create safer spaces globally as we collectively continue to face the challenge of the COVID-19 pandemic,” says Paul Ghezzi , CEO Kontrol. “Initial deliveries are set to arrive to Kontrol customers and distributors in January 2021 . Our team has been working around the clock to launch BioCloud into the global market.”

Manufacturing
With COVID-19 cases spiking globally and with increases anticipated into the winter season, BioCloud distribution plans are in high gear.

“We have the required local manufacturing capability to meet anticipated production volumes,” says Gary Saunders , VP of Kontrol. “We are pleased that the majority of our supply chain is Canadian.”

Kontrol has engaged OES Inc. a local design and contract manufacturer in London, Ontario to produce the BioCloud units. OES Inc. has a long and established history of assisting with the design and manufacturing of complex technology.

“Having BioCloud developed and now being produced in Ontario, Canada is very important to us,” continues Paul Ghezzi . “Our plans to have the initial production and supply chain sourced in Canada means that we are creating jobs while helping to solve the global pandemic that is COVID-19.”

“OES has the ability and capacity to ramp up to meet the required BioCloud manufacturing requirements and we can also scale with BioCloud as required,” says Jeff Stewart , President OES Inc. “We are committed to supporting local jobs, growth and Ontario exports.”

Kontrol receives additional federal funding
On December 3rd, 2020 the Company announced that it had received advisory services and additional $500,000 in research and development funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) .

“This is another important accomplishment and milestone for Kontrol and represents the continuing advancement of the BioCloud technology,” continues Paul Ghezzi . “We are grateful for and proud of this support from our federal government.”

Kontrol’s distribution agreement with United Safety and Survivability Corp
Under the terms of the agreement, the exclusivity applies to the industries defined as buses, rail and locomotive, subways, ambulances, fire trucks, first responder and military vehicles, with applicable associated facilities in the geography of North America , Australia , and New Zealand . The exclusivity period is 12 months with a six month mutual renewal option and is based on 5,000 units of BioCloud per annum, on a best efforts basis, to retain exclusivity. Pricing will not be disclosed for industry competitive purposes.

Joseph Mirabile , CEO of United Safety stated, “United Safety and Survivability Corporation is committed to delivering the most innovative and reliable solutions that our customers trust to protect life and property. We are very excited to be sharing the Kontrol BioCloud technology with all of our customers. We see interest and demand for this innovative technology, which can help create safer spaces and help our customers solve many of the challenges they are facing in relation to the impact COVID-19 has on their business.”

Ongoing Service
The patented and proprietary detection chamber is at the heart of BioCloud. The detection chamber is a consumable that needs to be replaced when it comes into contact with the SARS- CoV-2 virus. Kontrol is launching a new service to assist customers with the disposal and recycling of BioCloud’s propriety detection chamber.

The service allows for customers to return and recycle the detection chamber and receive a discount on future purchases of consumable detection chambers.

“This new service is a win-win as Kontrol is able to recycle various materials and customers are able to receive a discount on future purchases of the BioCloud consumables,” continues Gary Saunders .

Purchase
The Company estimates a $12,000 USD per unit sale price for BioCloud based on current supply chain components. However, the Company offers volume discounts for aggregate purchases and further, the Company will offer a financing plan should customers require it.

About Kontrol BioCloud
BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality over time. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, offices, retirement homes, hospitals, mass transportation and others.

Additional information about Kontrol BioCloud can be found on its website at www.kontrolbiocloud.com

About Kontrol Energy
Kontrol Energy Corp., a Canadian public company, is a leader in smart buildings and cities through IoT, Cloud and SaaS technology. Kontrol Energy provides a combination of software, hardware, and service solutions to its customers to improve energy management, air quality and continuous emission monitoring.

Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at www.sedar.com

Visit https://www.kontrolbiocloud.com/ for future updates, BioCloud demonstrations and to place orders.

Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

SOURCE Kontrol Energy Corporation

Tags: BioCloud, COVID-19, CSA, CSA Standards, CSE, energy conservation, google nest, small cap
Posted in Kontrol Energy Corp. | Comments Off on Canadian-made SARS-CoV-2 detector set to ship worldwide – Kontrol Energy Corp. $KNR $KNR.ca $KNR.c $KNRLF $SNE $MSFT $HON $GOOGL $QCOM $SONA.ca

Innocan $INNO.ca Pharma to Participate in the Lytham Partners End of Year 1×1 Conference $CGC.ca TLRY $VFF.ca $APHA $OVAT.ca $KHRN.ca

Posted by AGORACOM-JC at 4:08 PM on Thursday, December 3rd, 2020

Announced that it was invited by one of the leading IR agencies in the U.S., Lytham Partners, to participate in its End of Year 1×1 Conference (the “Conference”) from December 7-11, 2020.
CEO Iris Bincovich will be participating on behalf of Innocan and will showcase the Company in one-on-one meetings at the Conference.

Herzliya, Israel and Calgary, Alberta–(December 3, 2020) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (the “Company” or “Innocan”), is pleased to announce that it was invited by one of the leading IR agencies in the U.S., Lytham Partners, to participate in its End of Year 1×1 Conference (the “Conference”) from December 7-11, 2020. CEO Iris Bincovich will be participating on behalf of Innocan and will showcase the Company in one-on-one meetings at the Conference.

To arrange a one on one meeting, please contact Ben Shamsian of Lytham Partners at [email protected] or visit https://lythampartners.com/virtual/.

CEO Iris Bincovich states: “We are glad that Innocan was selected by Lytham Partners to participate in this important conference. This invitation outlines that we are on a promising path within our field of scientific work in combining CBD with liposomes and exosomes, to target serious diseases like Epilepsy, Alzheimer or Covid-19.”

About Innocan

The Company is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol (“CBD“). Innocan and Ramot at Tel Aviv University are collaborating on a new, revolutionary exosome-based technology that targets both central nervous system (CNS) indications and the Covid-19 Corona Virus using CBD. CBD-loaded exosomes hold the potential to help in the recovery of infected lung cells. This product, which is expected to be administrated by inhalation, will be tested against a variety of lung infections.

The Company signed a worldwide exclusive license agreement with Yissum, the commercial arm of the Hebrew University of Jerusalem to develop a CBD drug delivery platform based on a unique-controlled release liposome to be administrated by injection. The Company plans, together with Professor Berenholtz, Head of the Laboratory of Membrane and Liposome Research of the Hebrew University, to test the liposome platform on several potential indications. The Company is also working on a dermal product that integrates CBD with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals, including, but not limited to, topical treatments for relief of psoriasis symptoms as well as the treatment of muscle pain and rheumatic pain. The founders and officers of Innocan have commercially successful track records in the pharmaceutical and technology sectors in Israel and globally.

For further information, please contact:

For Innocan Pharma Corporation:
Iris Bincovich, CEO
+972-54-3012842
[email protected]

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Caution regarding forward-looking information

Certain information set forth in this news release, including, without limitation, information regarding the markets, requisite regulatory approvals and the anticipated timing for market entry, is forward-looking information within the meaning of applicable securities laws. By its nature, forward-looking information is subject to numerous risks and uncertainties, some of which are beyond Innocan’s control. The forward-looking information contained in this news release is based on certain key expectations and assumptions made by Innocan, including expectations and assumptions concerning the anticipated benefits of the products, satisfaction of regulatory requirements in various jurisdictions and satisfactory completion of requisite production and distribution arrangements.

Forward-looking information is subject to various risks and uncertainties which could cause actual results and experience to differ materially from the anticipated results or expectations expressed in this news release. The key risks and uncertainties include but are not limited to: general global and local (national) economic, market and business conditions; governmental and regulatory requirements and actions by governmental authorities; and relationships with suppliers, manufacturers, customers, business partners and competitors. There are also risks that are inherent in the nature of product distribution, including import / export matters and the failure to obtain any required regulatory and other approvals (or to do so in a timely manner) and availability in each market of product inputs and finished products. The anticipated timeline for entry to markets may change for a number of reasons, including the inability to secure necessary regulatory requirements, or the need for additional time to conclude and/or satisfy the manufacturing and distribution arrangements. As a result of the foregoing, readers should not place undue reliance on the forward-looking information contained in this news release concerning the timing of launch of product distribution. A comprehensive discussion of other risks that impact Innocan can also be found in Innocan’s public reports and filings which are available under Innocan’s profile at www.sedar.com.

Readers are cautioned that undue reliance should not be placed on forward-looking information as actual results may vary materially from the forward-looking information. Innocan does not undertake to update, correct or revise any forward looking information as a result of any new information, future events or otherwise, except as may be required by applicable law.

Tags: CBD Derma Cosmetics, CBD stocks, CSE, Innocan, Relief & Go Pain Relief Spray, small cap, smallcap stocks, stocks, tsx
Posted in Innocan Pharma Corporation | Comments Off on Innocan $INNO.ca Pharma to Participate in the Lytham Partners End of Year 1×1 Conference $CGC.ca TLRY $VFF.ca $APHA $OVAT.ca $KHRN.ca

House Gets Ready For Historic Vote On Federal Marijuana Prohibition SPONSOR Harborside $HBOR.ca $VFF.to $HARV.ca $ACB.to

Posted by AGORACOM at 1:03 PM on Thursday, December 3rd, 2020

SPONSOR: Harborside is a California-focused, vertically integrated, fully licensed cannabis company with its business consisting of three primary segments, Retail Dispensaries, Cultivation and Processing and Wholesale Sales (including branded product sales). Harborside operates the only drive through dispensary in California

This week the U.S. House of Representatives is expected to vote on a bill that would remove marijuana from the Controlled Substances Act and require federal courts to expunge many prior marijuana offenses. It will be the first time the full House will vote on ending the federal prohibition of cannabis.

Morgan Fox with the National Cannabis Industry Association says House passage would “send a really strong message to not only the rest of Congress, but to a lot of other states that the time to end prohibition has come.”

The Marijuana Opportunity Reinvestment and Expungement Act (MORE Act), introduced by Rep. Jerry Nadler (D., N.Y.), would eliminate conflict between state and federal law and allow states to set their own marijuana policies.

“We don’t need to have one size fits all. We just need to get rid of prohibition and then let the states do what the states are doing. It’s essentially what the states have done already. They haven’t waited for the federal government, which is why we have a lot of these discrepancies and challenges,” said Rep. Earl Blumenauer (D., Ore.), who has long pushed for marijuana legalization.

Blumenauer and Rep. Barbara Lee (D., Calif.) — who also wrote parts of the legislation — told Yahoo Finance the bill is a racial justice issue.

“It’s coming at a time when Americans are recognizing how hopelessly flawed the criminal justice system is,” said Blumenauer.

‘You’ve got to repair the damage’

The MORE Act would impose a 5% sales tax on marijuana and marijuana products. The revenue would go toward a new trust fund for grant programs designed to help people “adversely impacted by the War on Drugs” access job training, re-entry services, legal aid, treatment and more. The bill would also provide protections prohibiting denial of federal benefits based on use, possession or conviction for a marijuana offense.

“Regardless of who you are, if you’ve been incarcerated and if you’ve done your time and you get out, you should be provided for a second chance,” Lee told Yahoo Finance. “When you’ve been incarcerated or when you have have a record based on unjust laws — they’re really targeted in many ways, Black and Brown people — then you’ve got to make restitution, you’ve got to repair the damage. This fund is about the time that was lost because of barriers to employment, because of incarceration.”

The MORE Act would open up more opportunities for marijuana businesses, including access to Small Business Administration funding. It would also require the Bureau of Labor Statistics to gather demographic data on cannabis business owners and employees to ensure people of color and economically disadvantaged people are taking part in the industry.

“That really sets out a process for equity in the industry. This is a job-creating industry, and it also provides economic opportunities for minority-owned business owners,” said Lee.Graphic by David Foster/Yahoo Finance

The House Judiciary Committee passed the MORE Act last year 24 to 10 — Rep. Matt Gaetz (R., Fla.) and Rep. Tom McClintock (R., Calif.) were the only Republicans who voted for the bill.

In an interview with Yahoo Finance, McClintock said while he didn’t endorse marijuana, it’s clear U.S. marijuana laws have “not accomplished their goals.”

“These laws have done far more harm than good. They’ve created a violent underground economy and ruined the lives of so many young people who’ve had a youthful marijuana conviction, follow them and ruin their lives,” said McClintock.

The House was scheduled to vote on the bill in September, but Democratic leadership postponed the vote because some members in tight races worried passing the MORE Act before a stimulus package could hurt them at the polls.

Nearly a month after the election, there is still no additional coronavirus relief and many Republicans are again slamming Democrats for what they see as prioritizing the cannabis bill over coronavirus relief efforts.

Democrats have already passed two versions of the Heroes Act and argue it’s the Trump administration and Republican Senate that’s holding up stimulus talks.

SOURCE: https://finance.yahoo.com/news/house-gets-ready-for-historic-vote-on-federal-marijuana-prohibition-192829701.html

Tags: American CBD, california cannabis, Cannabis, Canopy Growth Corp, CSE, Greenhouse, Hemp, Record, Revenue, small cap, tsx
Posted in All Recent Posts, Harborside | Comments Off on House Gets Ready For Historic Vote On Federal Marijuana Prohibition SPONSOR Harborside $HBOR.ca $VFF.to $HARV.ca $ACB.to

Posts Tagged ‘small cap’

‘You’ve got to repair the damage’

Categories